keyword
https://read.qxmd.com/read/38619147/transient-acute-diplopia-as-a-rare-side-effect-of-hydromorphone-a-case-report
#1
JOURNAL ARTICLE
Leah J Lee, Brittani Bungart, Brian Wainger, Jonathan Gorky, Ashley So, Jingping Wang
Diplopia, or double vision, has been listed as a rare adverse effect of intravenous hydromorphone, although there are no case studies or literature documenting this. We detail a case of acute transient diplopia correlated with the use of intraoperative hydromorphone and postoperative hydromorphone patient-controlled analgesia. Although the mechanism for this adverse effect is unknown, there may be risk factors that predispose patients to the potential toxic metabolic effects of hydromorphone. We share the first published case of diplopia as a clinically relevant adverse effect of hydromorphone and propose a potential reason behind this association...
April 1, 2024: A&A Practice
https://read.qxmd.com/read/38598061/delayed-gastric-emptying-after-pancreatoduodenectomy-an-analysis-of-risk-factors
#2
JOURNAL ARTICLE
Juan Carlos Sabogal, Danny Conde Monroy, Carlos Eduardo Rey Chaves, Daniela Ayala, Juliana González
BACKGROUND: Delayed gastric emptying (DGE) is a frequent complication after pancreatoduodenectomy. Preoperative factors are limited and controversial. This study aims to identify associated factors related to this complication in the Colombian population. METHODS: A retrospective review of a prospectively collected database was conducted. All patients over 18 years of age who underwent pancreaticoduodenectomy were included. Associations with DGE syndrome were evaluated with logistic regression analysis, Odds ratio, and b-coefficient were provided when appropriate...
April 10, 2024: Updates in Surgery
https://read.qxmd.com/read/38590251/building-capacity-for-injectable-diacetylmorphine-and-hydromorphone-for-the-treatment-of-opioid-use-disorder-identifying-typical-doses
#3
JOURNAL ARTICLE
Tianna Magel, Lourdes Atziri Gonzalez Arreola, Daphne Guh, Scott MacDonald, Scott Harrison, Martin Schechter, Eugenia Oviedo-Joekes
Identifying typical doses of existing opioid use disorder medications, such as injectable opioid agonist treatment (iOAT), can support client and program needs, and potentially increase iOAT expansion. Longitudinal data from participants in a cohort study ( n  = 131), along with clinic dispensation records from August 2014 to April 2020, were used to examine physician prescribed as well as used doses of injectable diacetylmorphine and hydromorphone. Dosage groups, by medication and prescribed dose per session, were created for both hydromorphone and diacetylmorphine...
April 9, 2024: Journal of Psychoactive Drugs
https://read.qxmd.com/read/38564124/neuropsychiatric-effects-associated-with-opioid-based-management-for-palliative-care-patients
#4
REVIEW
Alan D Kaye, Kylie Dufrene, Jada Cooley, Madeline Walker, Shivam Shah, Alex Hollander, Sahar Shekoohi, Christopher L Robinson
PURPOSE OF REVIEW: The abundance of opioids administered in the palliative care setting that was once considered a standard of care is at present necessitating that providers evaluate patients for unintentional and deleterious symptomology related to aberrant opioid use and addiction. Polypharmacy with opioids is dynamic in affecting patients neurologically, and increased amounts of prescriptions have had inimical effects, not only for the individual, but also for their families and healthcare providers...
April 2, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38562627/fracture-management-in-chronic-kidney-disease-challenges-and-considerations-for-orthopedic-surgeons
#5
REVIEW
Wan Kee Hong, Sejoong Kim, Hyun Sik Gong
Orthopedic surgeons treating fractures need to consider comorbidities, including chronic kidney disease (CKD), which affects millions worldwide. CKD patients are at elevated risk of fractures due to osteoporosis, especially in advanced stages. In addition, fractures in CKD patients pose challenges due to impaired bone healing and increased post-fracture complications including surgical site infection and nonunion. In this article, we will discuss factors that must be considered when treating fractures in CKD patients...
April 2024: Clinics in Orthopedic Surgery
https://read.qxmd.com/read/38560545/trends-of-opioid-usage-in-surgical-patients-in-a-small-community-hospital-analysis-of-patient-data-between-2017-and-2021
#6
JOURNAL ARTICLE
Todd Leopold, Mark Gerschutz, Shantanu Rao
Purpose: The purpose of our study was to quantify and analyze the annual opioid usage in surgical patients at Wood County Hospital (WCH) between 2017 and 2021. Methods : In this retrospective study, patient data between 2017 and 2021 was analyzed to determine the oral morphine milligram equivalent (MME) of opioids used in surgical patients at WCH. Annual MME prescribed per admission was compared each year using one-way ANOVA followed by Tukey post hoc test. Similarly, the annual use of intravenous (IV) acetaminophen for surgical patients per admission was also calculated and analyzed using the one-way ANOVA followed by Tukey post hoc test...
December 2023: Hospital Pharmacy
https://read.qxmd.com/read/38559723/developing-aptamer-based-colorimetric-opioid-tests
#7
JOURNAL ARTICLE
Juan Canoura, Obtin Alkhamis, Matthew Venzke, Phuong T Ly, Yi Xiao
Opioids collectively cause over 80,000 deaths in the United States annually. The ability to rapidly identify these compounds in seized drug samples on-site will be essential for curtailing trafficking and distribution. Chemical reagent-based tests are fast and simple but also notorious for giving false results due to poor specificity, whereas portable Raman spectrometers have excellent selectivity but often face interference challenges with impure drug samples. In this work, we develop on-site sensors for morphine and structurally related opioid compounds based on in vitro-selected oligonucleotide affinity reagents known as aptamers...
March 25, 2024: JACS Au
https://read.qxmd.com/read/38537393/efficacy-of-bilateral-catheter-superficial-parasternal-intercostal-plane-blocks-using-programmed-intermittent-bolus-for-opioid-sparing-postoperative-analgesia-in-cardiac-surgery-with-sternotomy-a-randomized-double-blind-placebo-controlled-trial
#8
JOURNAL ARTICLE
Qi Li, Yi Liao, Xiaoe Wang, Mingying Zhan, Li Xiao, Yu Chen
STUDY OBJECTIVE: This study investigated whether catheter superficial parasternal intercostal plane (SPIP) blocks, using a programmed intermittent bolus (PIB) with ropivacaine, could reduce opioid consumption while delivering enhanced analgesia for a period exceeding 48 h following cardiac surgery involving sternotomy. DESIGN: A double-blind, prospective, randomized, placebo-controlled trial. SETTING: University-affiliated tertiary care hospital...
March 26, 2024: Journal of Clinical Anesthesia
https://read.qxmd.com/read/38534934/scheduled-and-breakthrough-opioid-use-for-cancer-pain-in-an-inpatient-setting-at-a-tertiary-cancer-hospital
#9
JOURNAL ARTICLE
Aline Rozman de Moraes, Elif Erdogan, Ahsan Azhar, Suresh K Reddy, Zhanni Lu, Joshua A Geller, David Mill Graves, Michal J Kubiak, Janet L Williams, Jimin Wu, Eduardo Bruera, Sriram Yennurajalingam
Background : Our aim was to examine the frequency and prescription pattern of breakthrough (BTO) and scheduled (SCH) opioids and their ratio (BTO/SCH ratio) of use, prior to and after referral to an inpatient supportive care consult (SCC) for cancer pain management (CPM). Methods and Materials : Patients admitted at the MD Anderson Cancer Center and referred to a SCC were retrospectively reviewed. Cancer patients receiving SCH and BTO opioids for ≥24 h were eligible for inclusion. Patient demographics and clinical characteristics, including the type and route of SCH and BTO opioids, daily opioid doses (MEDDs) of SCH and BTO, and BTO/SCH ratios were reviewed in patients seen prior to a SCC (pre-SCC) and during a SCC...
March 5, 2024: Current Oncology
https://read.qxmd.com/read/38528335/chronic-pain-management-in-a-cyp2d6-poor-metabolizer-a-case-report-for-oxycodone
#10
JOURNAL ARTICLE
Deepa Pednekar, Joshua Russell, Chandni Bardolia, David Thacker, Nishita Shah Amin
The objective of this case report is to illustrate pharmacogenomics (PGx)-guided oxycodone treatment, given the conflicting data on the analgesic response from oxycodone in Cytochrome P450 (CYP)2D6 poor metabolizers (PMs). PGx-guided therapy can help improve treatment outcomes. This case report describes a 58-year-old patient who was prescribed oxycodone for chronic pain management. The patient presented with a history of inadequate pain control despite analgesic treatment with oxycodone (morphine milliequivalent [MME] = 22...
April 1, 2024: Senior Care Pharmacist
https://read.qxmd.com/read/38511293/evaluation-of-the-analgesic-efficacy-of-grapiprant-compared-with-robenacoxib-in-cats-undergoing-elective-ovariohysterectomy-in-a-prospective-randomized-masked-non-inferiority-clinical-trial
#11
JOURNAL ARTICLE
Elizabeth K Pisack, Stephanie A Kleine, Chiara E Hampton, Christopher K Smith, Jennifer Weisent, Rebecca DeBolt, Cambrie Schumacher, Genevieve Bussières, Reza Seddighi
OBJECTIVES: The main objective of this study was to compare the postoperative analgesic effects of grapiprant with those of robenacoxib in cats undergoing ovariohysterectomy (OVH). METHODS: In total, 37 female cats (age range 4 months-10 years, weighing ⩾2.5 kg) were enrolled in a prospective, randomized, masked, non-inferiority (NI) clinical trial. Cats received oral robenacoxib (1 mg/kg) or grapiprant (2 mg/kg) 2 h before OVH. Analgesia was assessed via the Feline Grimace Scale (FGS), the Glasgow Composite Measure Pain Scale-Feline (CMPS-F), von Frey monofilaments (vFFs) and pressure algometry (ALG) 2 h before treatment administration, at extubation, and 2, 4, 6, 8, 18 and 24 hours after extubation...
March 2024: Journal of Feline Medicine and Surgery
https://read.qxmd.com/read/38497192/gastrointestinal-adverse-effects-associated-with-the-use-of-intravenous-oliceridine-compared-with-intravenous-hydromorphone-or-fentanyl-in-acute-pain-management-utilizing-adjusted-indirect-treatment-comparison-methods
#12
JOURNAL ARTICLE
Joseph Biskupiak, Gary Oderda, Diana Brixner, Todd L Wandstrat
Background: In the absence of head-to-head comparative data from randomized controlled trials, indirect treatment comparisons (ITCs) may be used to compare the relative effects of treatments versus a common comparator (either placebo or active treatment). For acute pain management, the effects of oliceridine have been compared in clinical trials to morphine but not to fentanyl or hydromorphone. Aim: To assess the comparative safety (specifically differences in the incidence of nausea, vomiting and opioid-induced respiratory depression [OIRD]) between oliceridine and relevant comparators (fentanyl and hydromorphone) through ITC analysis...
March 18, 2024: Journal of Comparative Effectiveness Research
https://read.qxmd.com/read/38493405/impact-of-replacing-fentanyl-with-hydromorphone-as-the-first-line-postoperative-opioid-among-patients-undergoing-outpatient-cancer-surgery
#13
JOURNAL ARTICLE
Jennifer R Majumdar, John Grbic, Sigrid Carlsson, Donna Barreiro, Marie Marte, Vincent Laudone, Melissa J Assel, Geema Masson
PURPOSE: In response to a nationwide fentanyl shortage, our institution assessed whether changing our first-line postoperative intravenous opioid from fentanyl to hydromorphone impacted patient outcomes. The primary research aim was to evaluate the association between first-line opioid and rapidity of recovery. DESIGN: The study team retrospectively obtained data on all consecutive patients extracted from the electronic medical record. The rapidity of recovery was defined as the time from entry into the postanesthesia care unit to the transition to Phase 2 for ambulatory extended recovery patients and as the length of total postanesthesia care unit stay for outpatients...
March 15, 2024: Journal of Perianesthesia Nursing: Official Journal of the American Society of PeriAnesthesia Nurses
https://read.qxmd.com/read/38469556/effect-of-intermittent-thoracic-paravertebral-block-on-postoperative-nausea-and-vomiting-following-thoracoscopic-radical-resection-of-the-lung-cancer-a-prospective-randomized-trial
#14
JOURNAL ARTICLE
Ting Ma, Yulong Yu, Haihua Cao, Huiqin Wang, Mingcang Wang
PURPOSE: To explore the benefits of ultrasound-guided intermittent thoracic paravertebral block (TPVB) combined with intravenous analgesia (PCIA) in alleviating postoperative nausea and vomiting (PONV) during video-assisted thoracic surgery (VATS). PATIENTS AND METHODS: 120 patients with lung carcinoma undergoing VATS were included and divided into three groups: group S (single TPVB+PCIA), group I (intermittent TPVB+PCIA), and group P (PCIA). The patients' NRS scores, postoperative hydromorphone hydrochloride consumption, and intramuscular injection of bucinnazine hydrochloride were recorded...
2024: Journal of Pain Research
https://read.qxmd.com/read/38457420/development-of-optimized-adult-epidural-infusion-preparations-to-reduce-waste-and-improve-operational-efficiency
#15
JOURNAL ARTICLE
Kathrine Donnowitz, Stephen F Eckel
DISCLAIMER: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: Despite national recommendations to standardize infusion concentrations, there is minimal guidance on institution-specific strategies and outcomes related to epidural infusion concentration standardization and optimization...
March 8, 2024: American Journal of Health-system Pharmacy: AJHP
https://read.qxmd.com/read/38413029/thermoresponsive-polymeric-hydromorphone-prodrug-provides-sustained-local-analgesia-without-apparent-adverse-effects
#16
JOURNAL ARTICLE
Zhenshan Jia, Xin Wei, Ningrong Chen, Xiaoke Xu, Gang Zhao, Xin Fu, Hanjun Wang, Mary B Goldring, Steven R Goldring, Dong Wang
The extensive use of opioids for chronic pain management has contributed significantly to the current opioid epidemic. While many alternative nonopioid analgesics are available, opioids remain the most potent analgesics for moderate to severe pain management. In addition to the implementation of multimodal analgesia, there is a pressing need for the development of more effective and safer opioids. In this study, we developed a thermoresponsive N -(2-hydroxypropyl) methacrylamide (HPMA) copolymer-based hydromorphone (HMP) prodrug (ProGel-HMP, HMP content = 16...
February 27, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38360531/effectiveness-of-perioperative-low-dose-esketamine-infusion-for-postoperative-pain-management-in-pediatric-urological-surgery-a-prospective-clinical-trial
#17
RANDOMIZED CONTROLLED TRIAL
Yanle Xie, Zenghui Liang, Shuhan Chen, Jing Liu, Huimin Lv, Fei Xing, Yuanyuan Mao, Yanling Ren, Xin Wei, Zhongyu Wang, Na Xing, Jianjun Yang, Xiyao Gu, Jingjing Yuan
BACKGROUND: Postoperative pain is common in pediatric urological surgery. The study assess the impact of perioperative intravenous infusion of low-dose esketamine on postoperative pain in pediatric urological surgery. METHODS: Pediatric patients (n = 80) undergoing urological surgery were randomized into four groups. Patients in the control group were administered an analgesic pump containing only hydromorphone at a dose of 0.1 mg/kg (Hydromorphone Group 1, H1) or 0...
February 15, 2024: BMC Anesthesiology
https://read.qxmd.com/read/38342769/hydromorphone-hydrochloride-preconditioning-combined-with-postconditioning-attenuates-myocardial-ischemia-reperfusion-injury-in-rats-by-improving-mitochondrial-function-and-activating-the-pi3k-akt-signaling-pathway
#18
JOURNAL ARTICLE
Liuji Qiu, Yan Yan, Guocheng Zhong, Zhiqi Hou, Yongcai Ye, Jiaying Lin, Dexing Luo
Thrombolytic therapy or percutaneous coronary intervention for myocardial infarction often cause myocardial ischemia/reperfusion injury (MIRI) and poor prognosis of patients. This study aimed to explore the protective effect and potential mechanism of hydromorphone hydrochloride (HH) on MIRI. Fifty Sprague-Dawley male rats were randomly divided into Sham group, I/R group, HH-pre group, HH-post group, and HH-pre + post group. Except Sham group, MIRI models were established by ligating and relaxing the left anterior descending coronary artery, followed by tail vein injection of HH (0...
February 2024: Chemical Biology & Drug Design
https://read.qxmd.com/read/38336528/eliminating-extended-release-opioids-from-a-postoperative-pain-protocol-for-total-knee-replacement-patients
#19
JOURNAL ARTICLE
Anoush Kalachian, Judith Barberio, Jill Cox
PURPOSE: To determine whether the elimination of extended release (ER) opioids in the multimodal medication regimen of total knee replacement (TKR) patients resulted in improved patient outcomes. DESIGN: Retrospective cohort quality improvement. METHODS: This project utilizes a retrospective chart review to evaluate an institution's current postoperative pain protocol. The outcomes of interest include mean hospital length of stay, discharge disposition, mean pain score, antiemetic use, mean opioid dose used, and number of opioid discharge prescriptions...
February 8, 2024: Pain Management Nursing: Official Journal of the American Society of Pain Management Nurses
https://read.qxmd.com/read/38326506/relationship-between-opioid-cross-tolerance-during-buprenorphine-stabilization-and-return-to-opioid-use-during-buprenorphine-dose-tapering
#20
JOURNAL ARTICLE
Mark K Greenwald, Tolani Sogbesan, Tabitha E H Moses
RATIONALE: Opioid injection drug use (IDU) has been linked to a more severe pattern of use (e.g. tolerance, overdose risk) and shorter retention in treatment, which may undermine abstinence attempts. OBJECTIVES: This secondary data analysis of four human laboratory studies investigated whether current opioid IDU modulates subjective abuse liability responses to high-dose hydromorphone during intermediate-dose buprenorphine stabilization (designed to suppress withdrawal but allow surmountable agonist effects), and whether hydromorphone response magnitude predicts latency of return to opioid use during buprenorphine dose-tapering...
February 8, 2024: Psychopharmacology
keyword
keyword
50944
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.